| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $29.1M | +21.3% | +32.4% |
| R&D Expense | $5.5M | +11.4% | -27.0% |
| SG&A Expense | $13.0M | +2.6% | -10.0% |
| Operating Income | -$15.8M | +18.2% | +29.7% |
| Pre-tax Income | -$27.2M | -4.8% | -8.3% |
| Income Tax | -$283K | -132.0% | +89.0% |
| Net Income | -$26.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $36.2M | +167.0% | +217.2% |
| Accounts Receivable | $35.2M | +10.4% | +3.9% |
| Current Assets | $84.7M | +46.2% | -48.8% |
| Total Assets | $200.2M | +7.2% | -40.5% |
| Current Liabilities | $64.7M | -0.3% | -74.1% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$41.2M | — | — |
| Capital Expenditures | $3.5M | — | — |
| Investing Cash Flow | -$3.5M | — | — |
| Financing Cash Flow | $64.9M | — | — |
| Free Cash Flow | -$44.7M | — | — |
| -0.3% |
| -23.6% |
| EPS (Basic) | -$0.41 | +24.1% | +28.1% |
| $35.4M |
| -5.2% |
| -52.0% |
| Total Liabilities | $184.2M | -0.7% | -49.1% |
| Stockholders' Equity | $16.0M | +1215.1% | +163.7% |